Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756515
Chatbot Implementation In The Clinical Informed Consent ProcessM.D. Anderson Cancer CenterNot Yet RecruitingNot Applicable
NCT07756515Not Yet Recruiting
Not Applicable
Chatbot Implementation In The Clinical Informed Consent ProcessM.D. Anderson Cancer Cent...
NCT07756333
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologiesyoussef alaaCompletedNot Applicable
NCT07756333Completed
Not Applicable
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologi...youssef alaa
NCT07754981
Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionUniversity of SheffieldNot Yet RecruitingNot Applicable
NCT07754981Not Yet Recruiting
Not Applicable
Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionUniversity of Sheffield
NCT07756047
Erector Spinae Plane vs Serratus Anterior Plane Catheter Infusions for Acute Pain Management in Patients With Traumatic Rib FracturesSunnybrook Health Sciences CentreNot Yet RecruitingNot Applicable
NCT07756047Not Yet Recruiting
Not Applicable
Erector Spinae Plane vs Serratus Anterior Plane Catheter Infusions for Acute Pai...Sunnybrook Health Science...
NCT07755267
Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Following Controlled, Oral Administration of Codeine Phosphate Tablets to 40 Healthy AdultsCliantha ResearchCompleted
NCT07755267Completed
—
Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Follo...Cliantha Research
NCT07756151
THE EFFECT OF BITTER ORANGE (CITRUS AURANTIUM) OIL AROMATHERAPY ON SLEEP QUALITY AND FATIGUE LEVELSUludag UniversityNot Yet RecruitingNot Applicable
NCT07756151Not Yet Recruiting
Not Applicable
THE EFFECT OF BITTER ORANGE (CITRUS AURANTIUM) OIL AROMATHERAPY ON SLEEP QUALITY...Uludag University
NCT07753824
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)Cancer Prevention Research Institute of TexasNot Yet RecruitingPhase 2
NCT07753824Not Yet Recruiting
Phase 2
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Pati...Cancer Prevention Researc...
NCT07755202
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory LeukemiaFlorian KuchenbauerNot Yet RecruitingPhase 2
NCT07755202Not Yet Recruiting
Phase 2
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapse...Florian Kuchenbauer
NCT07755137
Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical SettingsChildren's Hospital Los AngelesNot Yet RecruitingNot Applicable
NCT07755137Not Yet Recruiting
Not Applicable
Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behaviora...Children's Hospital Los A...
NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.AstraZenecaNot Yet RecruitingPhase 3
NCT07753993Not Yet Recruiting
Phase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult...AstraZeneca
NCT07755813
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department of DefenseNot Yet RecruitingPhase 2
NCT07755813Not Yet Recruiting
Phase 2
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department...
NCT07754266
Headache Ear Auditory Dizziness Sinus (HEADS) RegistryAssociation of Migraine DisordersRecruiting
NCT07754266Recruiting
—
Headache Ear Auditory Dizziness Sinus (HEADS) RegistryAssociation of Migraine D...
NCT07755605
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder: A Randomized Controlled TrialSamsung Medical CenterRecruitingNot Applicable
NCT07755605Recruiting
Not Applicable
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Dis...Samsung Medical Center
NCT07755722
Effect of Head Turn on Double-Lumen Tube AlignmentTaipei Veterans General Hospital, TaiwanCompletedNot Applicable
NCT07755722Completed
Not Applicable
Effect of Head Turn on Double-Lumen Tube AlignmentTaipei Veterans General H...
NCT07756320
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo ClinicEnrolling By Invitation
NCT07756320Enrolling By Invitation
—
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo Clinic
NCT07756268
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07756268Not Yet Recruiting
Phase 1
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio...
NCT07756099
Ba-Duan-Jin Training Versus NASM ApproachRashid Latif Medical CollegeCompletedNot Applicable
NCT07756099Completed
Not Applicable
Ba-Duan-Jin Training Versus NASM ApproachRashid Latif Medical Coll...
NCT07754682
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07754682Not Yet Recruiting
Phase 3
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in...Assistance Publique - Hôp...
NCT07754435
Neonatal Laparotomy - A Trial Investigating the Impact of Location of SurgeryGuy's and St Thomas' NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07754435Not Yet Recruiting
Not Applicable
Neonatal Laparotomy - A Trial Investigating the Impact of Location of SurgeryGuy's and St Thomas' NHS...
NCT07755228
Salivary Gasdermin E and Granzyme B Levels in Patients With PeriodontitisMedipol UniversityCompleted
NCT07755228Completed
—
Salivary Gasdermin E and Granzyme B Levels in Patients With PeriodontitisMedipol University
Result Breakdown
Not yet recruiting12 (60%)
Completed5 (25%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 32 (10%)
Phase 11 (5%)